Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib

AÇIKALIN A., BAĞIR KILIÇ E., PAYDAŞ S., ALSANCAK P., ERGİN M.

CUKUROVA MEDICAL JOURNAL, cilt.44, sa.2, ss.395-401, 2019 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.17826/cumj.442276
  • Dergi Adı: CUKUROVA MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.395-401
  • Çukurova Üniversitesi Adresli: Evet

Özet

Purpose: Multiple myeloma is a heterogeneous disease, for which an understanding of the prognostic and predictive value of chromosomal aberrations is necessary to prescribe the most appropriate therapy. We aimed to document the frequencies of chromosomal aberrations in our institute and searched the relationships between therapy regimens and chromosomal aberrations.